Jazz Pharmaceuticals PLC
(FRA:J7Z)
€
116.8
0.1 (0.09%)
Market Cap: 7.15 Bil
Enterprise Value: 10.62 Bil
PE Ratio: 17.16
PB Ratio: 1.77
GF Score: 83/100 Jazz Pharmaceuticals PLC at UBS Global Healthcare Virtual Conference Transcript
May 24, 2021 / 03:00PM GMT
Esther P. Rajavelu
UBS Investment Bank, Research Division - Analyst & Executive Director
Okay. Good morning, everyone. Thank you for joining us at the UBS Virtual Healthcare Conference day 1. I'm excited to have the Jazz management team here with us for a fireside chat. So I'm joined by Jazz Chairman and CEO, Bruce Cozadd; former GW Pharma CEO, Justin Gover; Renee Gala, Jazz' CFO; and Rob Iannone, EVP, R&D and Chief Medical Officer.
Welcome, and thank you all for making time for us.
Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO
Happy to be here, Esther.
Questions & Answers
Esther P. Rajavelu;
UBS Investment Bank, Research Division - Analyst & Executive Director
Great. So Bruce, perhaps we can start off with a big picture question as Jazz is positioned to become more diversified and you have a portfolio that provides you with multiple levers to pull. Where would you focus your resources and attention over the next 12 -- 24 to 36 months?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot